您当前的位置:
首页 >
文章列表页 >
Clinical advances in the application of romiplostim in primary immune thrombocytopenia
Review | 更新时间:2026-10-28
    • Clinical advances in the application of romiplostim in primary immune thrombocytopenia

    • Chin J Hosp Pharm   Vol. 46, Issue 17, Pages: 2074-2081(2026)
    • DOI:10.13286/j.1001-5213.2026.17.15    

      CLC: R973.1
    • Published:15 September 2026

    移动端阅览

  • LIU Jiaqi,LIU Xinguang,HOU Ming.Clinical advances in the application of romiplostim in primary immune thrombocytopenia[J].Chin J Hosp Pharm,2026,46(17):2074-2081. DOI: 10.13286/j.1001-5213.2026.17.15.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of information labeling pediatric medication in 2012 edition of National Essential Medicine List
Mechanistic study of Longsha Dingxuan Pills in posterior circulation ischemic vertigo using UPLC‑Q‑TOF‑MS/MS
Effect of triptolide on cyclosporine A pharmacokinetics in rats and the underlying mechanism
Grade 4 immune‑related liver injury following sintilimab therapy: a case report and practical guidance
Preparation and evaluation of flexible liposomes co‑loading baicalin and epigallocatechin gallate

Related Author

QIN Qian-qian
ZHANG Bo
WANG Xiao-ling
LU Tao-tao
ZHAO Rui-ling

Related Institution

Children’s Hospital of Shanxi
Department of Pharmacy,Peking Union Medical College Hospital
Department of Pharmacy,Beijing Children’s Hospital,Capital Medical University
0